dementing disease patients and healthy controls
Conditions
Interventions
None listed
Sponsors
Hamamatsu University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: about 800 subjects who underwent PET scans (FDG,PiB,DPA713,PK11195,PBB3,FBP/FMM,PM-PBB3,QAA,2FA,CFT,RAC,FMZ,Met,BCPP-EF,BU99008)
Exclusion criteria
Exclusion criteria: No
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To examine the differences between dementing disease patients and healthy controls for each PET tracer. | — |
Countries
Japan
Contacts
Public Contacttatsuhiro terada
Hamamatsu University School of Medicine HAMAMATSU BioPhotonics Innovation Laboratory
Outcome results
None listed